Skip to content

Patient Navigation in Cancer Survivorship at a Safety Net Institution

Patient Navigation as Part of the Cancer Survivorship Care Plan at a Safety Net Institution

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03271099
Enrollment
39
Registered
2017-09-01
Start date
2017-10-16
Completion date
2020-09-10
Last updated
2021-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

survivorship; navigation

Brief summary

This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.

Detailed description

This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan. Study participation for all participants will be for up to 9 months, with study visits approximately every 3 months, based on standard clinical follow-up. All participants will be administered quality of life surveys by a Clinical Research Associate at study entry, mid-study (approximately 3-6 months) and at study completion. The following factors will be compared between arms: * Missed/kept appointments * Use of urgent/emergent care * Quality of Life in relation to survivorship care * Participants lost to care

Interventions

Patient Navigation services will be provided to try to eliminate barriers in pursuing survivorship surveillance

Sponsors

Harvard Pilgrim Health Care
CollaboratorOTHER
Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast) * Completed treatment with curative intent within the past 12 months. (May be on maintenance therapy.)

Exclusion criteria

* Distant Metastatic disease * Non-curable disease * Recurrence of disease prior to enrollment * Require ongoing navigation from the treatment navigator * Enrolled/active in another randomized study (Project SUPPORT)

Design outcomes

Primary

MeasureTime frameDescription
Missed appointments9 monthsThe research team will document the number of cancer care appointments scheduled and of those, how many appointments were missed (obtained by medical record and by patient report in case a visit was outside of study institution).

Secondary

MeasureTime frameDescription
Urgent/emergent care9 monthsThe research team will document the number of urgent/emergent care visits attended within the study period of 9 months (obtained by medical record and by patient report in case a visit was outside of study institution).
Cancer Needs Distress9 monthsParticipants will rate their feelings about 39 specific cancer needs on a 5 point scale from Not a Problem to Very Severe Problem using the Cancer Needs Distress Inventory (CaNDI) tool. Total scores can range from 39 to 195. Lower scores are associated with less cancer related distress.
New Survivor Survey9 monthsParticipants will rate their understanding about 16 specific aspects of survivorship care on a 4 point scale from Strongly Disagree to Strongly Agree using the Preparing for Life as a New Survivor (PLANS) Scale. Total scores can range from 16 to 48. Lower scores are associated with less understanding of the survivorship care process.
Lost to Care9 monthsThe research team will document the number of participants lost to care, based on consecutive missed cancer care visits.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026